With photography platform SmugMug agreeing to buy Flickr from erstwhile Yahoo!, Flickr users have until May 25 to agree to new usage terms arising from the ownership change. While the transition will be automatic for current users of the site, it might be a good idea to revisit the new terms set by SmugMug.
According to the Flickr team, the acquisition has resulted in the accounts being governed by SmugMug’s terms of service and privacy policy for the platform.
Before SmugMug, Flickr was owned by Oath, the umbrella organization under Verizon (VZ) that looks after its units Yahoo! and AOL.
If you have a Flickr account, you might have received an e-mail that outlines the change in privacy and terms
Last month, many outlets reported that Yahoo mail also updated its terms. Yahoo told users that their mail would undergo additional scanning for advertising purposes. The new terms of service also brought changes to the company’s mutual arbitration clause – including the class action waiver – thereby bringing Yahoo’s policies in line with the Oath family of sites (AOL, Engadget, Huffington Post and Techcrunch.)
Coming back to photosharing, the Flickr team has assured that “nothing will change immediately with regard to your Flickr account.” SmugMug is looking to keep itself and Flickr as separate brands, thereby retaining the free and Pro Flickr accounts.
If you have a Flickr account, you might have received an electronic mail that outlines the change in terms, with links to the new ones as well.
After the May 25 deadline, Flickr accounts will automatically transition to SmugMug-determined terms of service and privacy policy. According to the update, “if you do not consent to SmugMug’s Terms and Privacy Policy, you will need to delete your Flickr account through your Account Settings.” However, Flickr does allow you to download a copy of your photos from your Camera Roll before that.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on